Giuseppe Ferrera

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

Susanna Esposito, S. Tansey, Allison Thompson et al. · Clinical and Vaccine Immunology · 2010 · 144 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy

Alessandro Zanetti, Antonino Parlato, Luisa Romanò et al. · Vaccine · 2012 · 34 citations

Medicine, Immunology, Pediatrics +14

Safety and immunogenicity of a measles–mumps–rubella–varicella vaccine given as a second dose in children up to six years of age

Scott A. Halperin, Giuseppe Ferrera, David W. Scheifele et al. · Vaccine · 2009 · 28 citations

Medicine, Immunology, Pediatrics +12

[The 2014 lifetime immunization schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Health. Italian Society of Pediatrics. Italian Federation of Pediatric Physicians. Italian Federation of General Medical Physicians. Arezzo Service of Legal Medicine].

Paolo Bonanni, Chiara Azzari, Paolo Castiglia et al. · PubMed · 2015 · 27 citations · Full text

Medicine, Pediatrics, Preventive Medicine +15

Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn – outcome of a cross-sectional conjoint experiment in Spain and Italy

Edouard Ledent, Giovanni Gabutti, Esther W. de Bekker‐Grob et al. · Human Vaccines & Immunotherapeutics · 2019 · 27 citations · Full text

Public Health, Child Health, Preventive Medicine +17